Replies to post #435 on Outlook Therapeutics Inc (OTLK)

[Glider549]

Question;
If they are seeking a buyer, wouldn't that lower the value of the company especially if they are in a hurry?
Is this the norm with them?

[thermo]

H2R, sorry I didn’t respond… I haven’t been on these boards for a month.

I think it’s too early for buyout negotiations. Although I can see a very large potential market for DCVax, I can also see other questions that have to be answered before large pharma steps in. They are very risk adverse. That said, I’m not bothered by that at all. I really never think about buyouts. They happen when everything is going well but I just focus on if a company is trending toward doing well, which is certainly the case with NWBO.

W.R.T. 9 meters biopharma. I own it but I’m not buying more down here. Once I have a relationship with management (which is the case here), I tend to keep a least a small position and stay in touch in management. If something changes, I’ll notice and scale up.

Glad to see you here in OTLK. Institutional investors are skeptical, thinking ONS 5010 won’t get much penetration, but management very optimistic. Step edit programs / health care cost issues aren’t going away and the next innovation isn’t changing that.

[thermo]